You are here
Pharma giant MSD joins A*Star's iPSP consortium
MSD International GmbH (Singapore Branch), one of the top five leading pharmaceutical companies globally, has joined A*Star's Innovative Processing for Specialties and Pharmaceuticals Programme (iPSP).
This consortium is led by A*Star's Institute of Chemical & Engineering Sciences and brings together pharmaceutical and specialty chemicals industry players to address the growing need to access emerging next generation manufacturing technologies.
These technologies provide quantum change improvements in cost, quality, environmental impact and process robustness in high value chemicals manufacturing processes.
Since its inception in July 2013, iPSP has been addressing key challenges in the high value chemicals sector, through a collaborative approach, said A*Star in a release on Thursday.
Its membership has expanded from its three founding members, Pfizer, Glaxo Smith-Kline and Siemens, to include technology leaders such as Hellma Analytics, Mettler Toledo and Novozymes, as well as leading academic institutions, National University of Singapore and Newcastle University International Singapore.